Hostname: page-component-74656f9884-rdgjk Total loading time: 0 Render date: 2026-11-07T00:35:47.124Z Has data issue: false hasContentIssue false

Crystal structure from laboratory X-ray powder diffraction data, DFT-D calculations, and Hirshfeld surface analysis of (S)-dapoxetine hydrochloride

Published online by Cambridge University Press:  13 September 2022

Analio J. Dugarte-Dugarte
Affiliation:
Laboratorio de Cristalografía-LNDRX, Departamento de Química, Facultad de Ciencias, Universidad de los Andes, Mérida 5101, Venezuela
Robert A. Toro
Affiliation:
Grupo de Investigación en Química Estructural (GIQUE), Escuela de Química, Facultad de Ciencias, Universidad Industrial de Santander, Bucaramanga, Colombia
Jacco van de Streek
Affiliation:
Avant-garde Materials Simulation, Alte Str. 2, D-79249 Merzhausen, Germany
José Antonio Henao
Affiliation:
Grupo de Investigación en Química Estructural (GIQUE), Escuela de Química, Facultad de Ciencias, Universidad Industrial de Santander, Bucaramanga, Colombia
Graciela Díaz de Delgado
Affiliation:
Laboratorio de Cristalografía-LNDRX, Departamento de Química, Facultad de Ciencias, Universidad de los Andes, Mérida 5101, Venezuela
José Miguel Delgado*
Affiliation:
Laboratorio de Cristalografía-LNDRX, Departamento de Química, Facultad de Ciencias, Universidad de los Andes, Mérida 5101, Venezuela
*
a)Author to whom correspondence should be addressed. Electronic mail: jmdq2000@gmail.com

Abstract

The previously unreported crystal structure of (S)-Dapoxetine hydrochloride (DAPHCl), the only active pharmaceutical ingredient specially developed for the treatment of premature ejaculation in men, has been determined from laboratory X-ray powder diffraction data with DASH and refined by the Rietveld method with TOPAS-Academic. The structure was evaluated and optimized by dispersion-corrected DFT calculations. This compound crystallizes in an orthorhombic cell, space group P212121, with unit-cell parameters a= 6.3208(3) Å, b = 10.6681(5) Å, c = 28.1754(10) Å, V = 1899.89(14) Å3, Z = 4. The refinement converged to Rp = 0.0442, Rwp = 0.0577, and GoF = 2.440. The crystal structure is a complex 3D arrangement of DAPHCl moieties held together by hydrogen bonds, π⋯π, and C–H⋯π interactions. The chloride ions form layers parallel to the ab plane and are connected by dapoxetinium moieties through N–H⋯Cl and C–H⋯Cl hydrogen bonds. These layers stack along the c-axis, which are connected by C–H⋯π interactions. Hirshfeld surface analysis and fingerprint plot calculations have been performed.

Information

Type
New Diffraction Data
Copyright
Copyright © The Author(s), 2022. Published by Cambridge University Press on behalf of International Centre for Diffraction Data
Figure 0

Figure 1. Molecular diagram of Dapoxetine hydrochloride (DAPHCl).

Figure 1

Figure 2. Superposition of the reported powder patterns of Form A and Form B with the powder pattern recorded in the present study.

Figure 2

Figure 3. Rietveld plot obtained after the structure refinement of DAPHCl.

Figure 3

Figure 4. Molecular structure of DAPHCl with the labeling scheme for atoms and rings.

Figure 4

Figure 5. Superposition of the experimentally determined (red) and the energy-minimized (blue) structure for DAPHCl.

Figure 5

TABLE I. Crystal data, experimental parameters, and refinement results for DAPHCl

Figure 6

Figure 6. View of the packing arrangement along the a-axis showing the hydrogen bond environment around the Cl− ions.

Figure 7

TABLE II. Geometry of hydrogen bonds, π⋯π, and C–H⋯π interactions in DAPHCl

Figure 8

Figure 7. View of the packing arrangement along the a-axis showing the sequence of π⋯π (magenta) and C–H⋯π (cyan) interactions.

Figure 9

Figure 8. dnorm, shape index, and curvedness mapped onto the HS for DAPHCl.

Figure 10

Figure 9. Stacking of DAPHCl molecules due to π⋯π and H⋯π interactions.

Figure 11

Figure 10. Fingerprint plots and percent contributions of important interactions in the structure of DAPHCl.

Supplementary material: File

Dugarte-Dugarte et al. supplementary material

Dugarte-Dugarte et al. supplementary material

Download Dugarte-Dugarte et al. supplementary material(File)
File 250.9 KB